eIF5A inhibition influences T cell dynamics in the pancreatic microenvironment of the humanized mouse model of Type 1 Diabetes. Scientific Reports, 2019; 9 (1) DOI: 10.1038/s41598-018-38341-5; ...

Disclaimer: AlphaGalileo is not responsible for the accuracy of content posted to AlphaGalileo by contributing institutions ...

Scientists from the NIH have developed a mouse model of type 2 diabetes. Type 2 diabetes is a common endocrinological disorder that affects between six and ten percent of the Western world. As ...

A pretreatment step could help transplanted pancreatic islets survive longer in patients with type 1 diabetes, according to a ...

The nonobese diabetic mouse as a model of autoimmune diabetes - immune dysregulation gets the NOD. Immunity 7 , 727–738 (1997). Article CAS Google Scholar ...

Finding new treatments or a cure for type I diabetes has been elusive in part because scientists have not had a reliable animal model that mimics the full scope of human type I diabetes. A ...

These drugs, which mimic the gut hormone glucagon-like peptide-1 (GLP-1), can help treat those with type 2 diabetes by stimulating the production of insulin and improving the function of beta cells.

At right, there are far fewer insulin-producing cells in an islet from a mouse carrying the mutation that causes neonatal diabetes. Credit: Molecular Metabolism (2025). DOI: 10.1016/j.molmet.2025. ...

Tests in mouse models of diabetes suggests that an experimental drug could help 'regrow' insulin-producing beta cells, thereby reversing the disease. Medical News Today Health Conditions ...

While not as dramatic as beta-cell TXNIP knockouts, the alpha-cell knockout improved diabetes-associated hyperglycemia and hyperglucagonemia in a mouse model of streptozotocin-induced diabetes.

People with diabetes are more prone to developing Staphylococcus aureus, ... The researchers brought their labs together to conduct a study with antibiotics in a diabetic mouse model of the Staph ...